{
    "Trade/Device Name(s)": [
        "ImmunoCAP Allergen o215, Component nGal-alpha-1,3-Gal (alpha-Gal) Thyroglobulin, bovine",
        "ImmunoCAP Specific IgE"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K200279",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051218"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "January 31, 2020",
    "Summary Letter Received Date": "February 4, 2020",
    "Submission Date": "April 30, 2020",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) Immunological Test System"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "alpha-Gal specific IgE"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 250",
        "Phadia Instrument Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Automated in vitro quantitative assay",
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Allergen o215, alpha-Gal, a fluorescent enzyme immunoassay for the measurement of allergen-specific IgE antibodies in human serum and EDTA plasma",
    "Indications for Use Summary": "Intended for in vitro diagnostic use, in human serum or EDTA plasma, as an aid in the diagnosis of IgE mediated mammalian meat hypersensitivity due to alpha-Gal sensitization, used in conjunction with other clinical findings",
    "fda_folder": "Immunology"
}